Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

SMTI - Sanara MedTech Inc. Stock Price, Fair Value and News

$21.20+1.00 (+4.95%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

SMTI Price Action

Last 7 days

2.1%

Last 30 days

-26.9%

Last 90 days

-37.7%

Trailing 12 Months

-41.7%

SMTI Stock Price

SMTI RSI Chart

MarAprMayJunJulAugSepOctNovDec0102030405060708090

SMTI Valuation

Market Cap

189.4M

Price/Earnings (Trailing)

-5.05

Price/Sales (Trailing)

2.43

EV/EBITDA

66.81

Price/Free Cashflow

-224.97

SMTI Price/Sales (Trailing)

202320242025246810

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SMTI Fundamentals

SMTI Revenue

Revenue (TTM)

78.1M

Rev. Growth (Yr)

21.51%

Rev. Growth (Qtr)

4.63%

2012201420162018202020222024020M40M60M80M

SMTI Earnings

Earnings (TTM)

-37.5M

Earnings Growth (Yr)

-964.19%

Earnings Growth (Qtr)

-1.4K%

2012201420162018202020222024-40M-30M-20M-10M0

SMTI Profitability

Operating Margin

89.88%

EBT Margin

-9.46%

Return on Equity

-610.29%

Return on Assets

-52.72%

Free Cashflow Yield

-0.44%

SMTI Investor Care

Shares Dilution (1Y)

2.23%

Diluted EPS (TTM)

-4.22

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
2012201420162018202020222024010M20M30M40M50M60M70M80M
Net sales
YearQ1Q2Q3Q4
20250000
202468.0M72.4M78.1M0
202353.6M59.6M62.6M65.0M
202226.9M30.3M37.6M45.8M
202115.6M18.9M20.4M24.1M
202015.8M15.7M17.1M17.1M
20196.4M7.1M8.5M11.8M
20186.7M7.5M7.5M5.8M
20176.0M6.2M6.4M6.3M
20163.5M4.0M4.5M5.5M
20153.0M3.2M3.4M3.4M
20142.0M2.2M2.4M2.6M
20131.4M1.6M1.7M1.7M
20121.4M1.4M1.6M1.2M
20111.2M1.6M1.9M2.2M
2010000910.4K
Get all data in R, Python etc through our Historical Stock Data APIs

About Sanara MedTech Inc.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
 WEBSITEhttps://sanaramedtech.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES101

Sanara MedTech Inc. Frequently Asked Questions

What is the ticker symbol for Sanara MedTech Inc.? What does SMTI stand for in stocks?

SMTI is the stock ticker symbol of Sanara MedTech Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Sanara MedTech Inc. (SMTI)?

As of Wed Dec 03 2025, market cap of Sanara MedTech Inc. is 189.44 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SMTI stock?

You can check SMTI's fair value in chart for subscribers.

Is Sanara MedTech Inc. a good stock to buy?

The fair value guage provides a quick view whether SMTI is over valued or under valued. Whether Sanara MedTech Inc. is cheap or expensive depends on the assumptions which impact Sanara MedTech Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SMTI.

What is Sanara MedTech Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, SMTI's PE ratio (Price to Earnings) is -5.05 and Price to Sales (PS) ratio is 2.43. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SMTI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Sanara MedTech Inc.'s stock?

In the past 10 years, Sanara MedTech Inc. has provided 0.117 (multiply by 100 for percentage) rate of return.